Advisors Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,555
Closed -$8.76K 1484
2023
Q1
$8.76K Sell
7,555
-10,124
-57% -$18.5K ﹤0.01% 1422
2022
Q4
$47.4K Sell
17,679
-7,778
-31% -$20.5K ﹤0.01% 1344
2022
Q3
$73K Sell
25,457
-3,610
-12% -$15.4K ﹤0.01% 1311
2022
Q2
$144K Sell
29,067
-2,985
-9% -$15.6K ﹤0.01% 1226
2022
Q1
$228K Buy
32,052
+8,353
+35% +$69.1K ﹤0.01% 1200
2021
Q4
$431K Buy
23,699
+13,858
+141% +$299K 0.01% 1045
2021
Q3
$192K Buy
9,841
+6,672
+211% +$254K ﹤0.01% 1217
2021
Q2
$142K Buy
3,169
+2,124
+203% +$98.5K ﹤0.01% 1259
2021
Q1
$52K Buy
+1,045
New +$71.2K ﹤0.01% 1409

Other funds holding CELL

Advisors Asset Management's CELL Position: Q2 2023 in Review

Advisors Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 7,555 shares — an estimated $8.76K sold.

Advisors Asset Management first reported a position in CELL in Q1 2021 and held it in 9 quarters. The position peaked at $431K in Q4 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Advisors Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Advisors Asset Management sold 7,555 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $8.76K.
  • Advisors Asset Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Advisors Asset Management's PhenomeX Inc. Common Stock position peaked at $431K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Advisors Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.